JNJ's three largest insider shareholders as of June 02, 2026 are Alex Gorsky (Chairman, Ceo, 766.58K shares), Joaquin Duato (Ceo And Chairman Of The Board, 324.45K shares), Jennifer L Taubert (Evp, Wwc. Innovative Medicine, 194.45K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| John C Reed | Evp, Innovative Medicine, Rd | 10,658 | 0 | 18 Feb, 2026 |
| John G Morikis | - | 1,849 | 0 | 01 Dec, 2025 |
| Mathai Mammen | Evp, Pharm, Rd | 41,934 | 0 | 16 Feb, 2022 |
| Alex Gorsky | Chairman, Ceo | 766,584 | 0 | 18 Jan, 2023 |
| Peter Fasolo | Exec Vp, Chief Hr Officer | 112,076 | 0 | 15 Feb, 2024 |
| Michael H Ullmann | Exec Vp, General Counsel | 158,835 | 0 | 16 Feb, 2022 |
| Joaquin Duato | Ceo And Chairman Of The Board | 324,447 | 0 | 18 Feb, 2026 |
| Joseph J Wolk | Exec Vp, Cfo | 14,000 | 0 | 18 Feb, 2026 |
| Ashley Mcevoy | Evp, Ww Chair, Medtech | 52,038 | 0 | 25 Aug, 2023 |
| Jennifer L Taubert | Evp, Wwc. Innovative Medicine | 194,451 | 0 | 18 Feb, 2026 |
| Kathryn E Wengel | Evp, Chief To And Risk Officer | 114,288 | 0 | 18 Feb, 2026 |
| Thibaut Mongon | Exec Vp, Ww Chair, Cons Health | 65,915 | 0 | 15 Feb, 2023 |
| Mark A Weinberger | - | 1,000 | 0 | 12 Dec, 2024 |
| Robert J Decker | Vp Corporate Controller | 23,682 | 0 | 03 Mar, 2026 |
| James D. Swanson | Evp, Cio | 25,698 | 0 | 18 Feb, 2026 |
| Vanessa Broadhurst | Evp, Global Corp Affairs | 23,003 | 0 | 18 Feb, 2026 |
| William Hait | - | 38,647 | 0 | 15 Feb, 2024 |
| Elizabeth Forminard | Evp, Chief Legal Officer | 23,568 | 0 | 18 Feb, 2026 |
| Timothy Schmid | Evp, Ww Chair, Medtech | 25,447 | 0 | 23 Feb, 2026 |
| Kristen Mulholland | Evp, Chief Hr Officer | 19,830 | 0 | 18 Feb, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 10 Mar, 2026 | Eugene A. Woods | Deferred Share Units | A | 155 | $242.14 | 5,240 | D | A |
| 10 Mar, 2026 | Daniel E Pinto | Deferred Share Units | A | 129 | $242.14 | 462 | D | A |
| 10 Mar, 2026 | Daniel E Pinto | Deferred Share Units | A | 129 | $242.14 | 462 | D | A |
| 10 Mar, 2026 | Eugene A. Woods | Deferred Share Units | A | 155 | $242.14 | 5,240 | D | A |
| 10 Mar, 2026 | Eugene A. Woods | Deferred Share Units | A | 155 | $242.14 | 5,240 | D | A |
| 10 Mar, 2026 | Daniel E Pinto | Deferred Share Units | A | 129 | $242.14 | 462 | D | A |
| 10 Mar, 2026 | Eugene A. Woods | Deferred Share Units | A | 155 | $242.14 | 5,240 | D | A |
| 10 Mar, 2026 | Daniel E Pinto | Deferred Share Units | A | 129 | $242.14 | 462 | D | A |
| 27 Feb, 2026 | Robert J Decker | Common Stock | A | 4,075 | $115.67 | 27,757 | D | M |
| 27 Feb, 2026 | Robert J Decker | Common Stock | D | 4,075 | $247.87 | 23,682 | D | S |
| 27 Feb, 2026 | Robert J Decker | Employee Stock Options (Right to Buy) | D | 4,075 | $0.00 | 0 | D | M |
| 20 Feb, 2026 | Timothy Schmid | Common Stock | D | 1,322 | $245.66 | 25,447 | D | S |
| 20 Feb, 2026 | Timothy Schmid | Common Stock | D | 1,322 | $245.66 | 25,447 | D | S |
| 20 Feb, 2026 | Timothy Schmid | Common Stock | D | 1,322 | $245.66 | 25,447 | D | S |
| 20 Feb, 2026 | Timothy Schmid | Common Stock | D | 1,322 | $245.66 | 25,447 | D | S |
| 13 Feb, 2026 | James D. Swanson | Common Stock | A | 447 | $0.00 | 19,298 | D | M |
| 13 Feb, 2026 | Kristen Mulholland | Common Stock | A | 410 | $0.00 | 16,819 | D | M |
| 13 Feb, 2026 | Timothy Schmid | Common Stock | A | 499 | $0.00 | 22,624 | D | M |
| 13 Feb, 2026 | Jennifer L Taubert | Common Stock | A | 1,302 | $0.00 | 179,315 | D | M |
| 13 Feb, 2026 | Timothy Schmid | Common Stock | A | 499 | $0.00 | 22,624 | D | M |